We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

67 hedge funds and large institutions have $796M invested in Stoke Therapeutics in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 15

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

5% more funds holding

Funds holding: 64 → 67 (+3)

3.24% more ownership

Funds ownership: 102.3% → 105.54% (+3.2%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

16% less capital invested

Capital invested by funds: $948M → $796M (-$152M)

Holders
67
Holders Change
+3
Holders Change %
+4.69%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
12
Increased
29
Reduced
15
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$28.3M
2
BlackRock
BlackRock
New York
+$11.2M
3
AG
Artal Group
Luxembourg
+$6.18M
4
Victory Capital Management
Victory Capital Management
Texas
+$5.57M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$4.94M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$14.5M
2
SFM
Sphera Funds Management
Israel
-$5.66M
3
Millennium Management
Millennium Management
New York
-$5.16M
4
American Century Companies
American Century Companies
Missouri
-$4.06M
5
GGHC
Gilder Gagnon Howe & Co
New York
-$3.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$120K +$97.8K +3,958 +314%
Morgan Stanley
52
Morgan Stanley
New York
$117K -$306K -12,398 -71%
UBS Group
53
UBS Group
Switzerland
$100K -$118K -4,769 -52%
Ensign Peak Advisors
54
Ensign Peak Advisors
Utah
$94K -$123K -4,987 -55%
Legal & General Group
55
Legal & General Group
United Kingdom
$60K +$20.2K +816 +45%
SO
56
STRS Ohio
Ohio
$54K – – –
AIP
57
Ameritas Investment Partners
Nebraska
$34K +$17.8K +719 +94%
Canada Life
58
Canada Life
Manitoba, Canada
$17K – – –
US Bancorp
59
US Bancorp
Minnesota
$14K +$14.8K +600 New
VFA
60
Valeo Financial Advisors
Indiana
$9K +$7.51K +304 +227%
TPWA
61
TRUE Private Wealth Advisors
Oregon
$9K +$9.88K +400 New
Simplex Trading
62
Simplex Trading
Illinois
$8K +$9.22K +373 New
Daiwa Securities Group
63
Daiwa Securities Group
Japan
$4K – – –
AIM
64
Anchor Investment Management
South Carolina
$3.94K – – –
First Manhattan
65
First Manhattan
New York
$3K +$3.71K +150 New
Royal Bank of Canada
66
Royal Bank of Canada
Ontario, Canada
$2K -$18.8K -759 -90%
TFA
67
Toth Financial Advisory
Virginia
$1K +$1.48K +60 New
American Century Companies
68
American Century Companies
Missouri
– -$4.06M -143,327 Closed
ZP
69
Zimmer Partners
New York
– -$708K -25,000 Closed
Squarepoint
70
Squarepoint
New York
– -$574K -20,286 Closed
GPCM
71
Granite Point Capital Management
Massachusetts
– -$374K -13,200 Closed
AC
72
Athanor Capital
New York
– -$273K -9,657 Closed
ProShare Advisors
73
ProShare Advisors
Maryland
– -$236K -8,317 Closed
FAM
74
Fred Alger Management
New York
– -$170K -6,000 Closed
AS
75
Altshuler Shaham
Israel
– -$35K -1,234 Closed
1 2
3
4

STOK Hedge Fund Activity: Q1 2020 in Review

67 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q1 2020, worth a combined $796M — down 16% from $948M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new STOK positions and 9 closed out — a net gain of 3 holders — while 29 added to existing stakes and 15 trimmed.

The largest buyer was Redmile Group, adding an estimated $28.3M. The largest seller was Janus Henderson Group, cutting an estimated $14.5M.

  • 67 institutional investors held Stoke Therapeutics (STOK) as of Q1 2020, up from 64 in Q4 2019.
  • Funds reported $796M of Stoke Therapeutics stock for Q1 2020, down 16% quarter-over-quarter.
  • 12 funds opened new Stoke Therapeutics positions in Q1 2020 and 9 closed out, a net change of +3 holders.
  • The largest Stoke Therapeutics buyer in Q1 2020 was Redmile Group, an estimated $28.3M added.
  • The largest Stoke Therapeutics seller in Q1 2020 was Janus Henderson Group, an estimated $14.5M sold.

Based on aggregated 13F filings for Q1 2020.